APA (7th ed.) Citation

NI, N., R, B., AA, A., AF, A., MS, A., & MA, A. (2026). Enhancement of oral bioavailability of risedronate through xyloglucan rafts. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 28, 15525. https://doi.org/10.3389/jpps.2025.15525

Chicago Style (17th ed.) Citation

NI, Namazi, Bafail R, Alanezi AA, Almuqati AF, Alshammari MS, and Alghamdi MA. "Enhancement of Oral Bioavailability of Risedronate Through Xyloglucan Rafts." Journal of Pharmacy & Pharmaceutical Sciences : A Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques 28 (2026): 15525. https://doi.org/10.3389/jpps.2025.15525.

MLA (9th ed.) Citation

NI, Namazi, et al. "Enhancement of Oral Bioavailability of Risedronate Through Xyloglucan Rafts." Journal of Pharmacy & Pharmaceutical Sciences : A Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques, vol. 28, 2026, p. 15525, https://doi.org/10.3389/jpps.2025.15525.

Warning: These citations may not always be 100% accurate.